Study Patients
One hundred and 58 consecutive patients with a history suggesting variant angina or unstable angina were examined by the EAGLE system and coronary cineangiography with the ergonovine provocation test between April 1992 and December 1994. During monitoring, intravenous heparin was given to patients and all other anti-anginal agents were withheld from 12 to 24 h before starting monitoring. Thirty-five of the patients were diagnosed as having vasospastic angina without fixed coronary stenosis, and angina attacks associated with ST elevation were detected by the EAGLE system in 26 of them. These 26 patients were followed up for at least 3 years, and were the subjects of the present study.
Cardiac catheterization was performed with the standard Judkins' technique in the morning after an overnight fast and without anti-angina medications, except in patients for whom it was judged dangerous to discontinue therapy. The Jpn Circ J 1999; 63: 509 -513 (Received February 2, 1999 ; revised manuscript received March 16, 1999; accepted March 23, 1999 standard 12-lead ECG was recorded. After confirming that there was no significant organic stenosis (>75% luminal narrowing in at least 1 major vessel), the ergonovine provocation test was performed. Ergonovine (0.4 mg) was dissolved in physiological saline, and incremental doses (0.05 mg, 0.15 mg and 0.2 mg) were injected intravenously at 3-min intervals. This test was not performed in patients who were taking anti-anginal medications and who had had spontaneous coronary spasm during preparation for catheterization. When angina or ST segment elevation occurred after ergonovine provocation, coronary arteriography was immediately performed. When neither chest pain nor ECG changes were observed, coronary cineangiography was repeated to confirm the absence of spasm, and isosorbide dinitrate was administered intravenously. Then coronary angiograms were again recorded in multiple views to assess organic stenosis.
The diagnosis of vasospastic angina without fixed coronary stenosis was made when patients experienced an angina attack with ST elevation during EAGLE monitoring and where coronary angiograms confirmed that there was no significant coronary narrowing.
Data Analysis
The ST segment elevation was analyzed using the workstation. The appearance of a transient ST elevation or depression of more than 0.10 mV at 0.08 s after the J point in at least 2 leads was considered diagnostic of myocardial ischemia caused by coronary spasm. The site of ischemia was defined as the anterior wall when ST elevation occurred in leads V1-4, whereas it was defined as the lateral wall when elevation occurred in leads I, aVL, V5 and V6, and as the inferior wall when changes occurred in leads II, III, and aVF. ST elevation in more than one of these regions during the same or different angina attacks was considered to be evidence of multivessel spasm. We divided multivessel spasm into 3 types. The first type was spasm affecting different vascular regions on different occasions (migratory type), the second type was spasm that occurred successively in 2 different regions (sequential type), and the third type was simultaneous spasm affecting more than one vascular region (simultaneous type). Angina attacks that produced only ST depression were excluded from analysis of the site of ischemia. During EAGLE system recording, 2 patients displayed ST segment depression in all leads except aVR and had transient cardiogenic shock. These patients showed left main coronary artery spasm on coronary angiography and were included in this study as representative of simultaneous multivessel spasm.
Treatment and Follow-up
After discharge, the patients were reviewed every month at the outpatient department, affiliated hospitals, or private clinics. At each visit, standardized questions were asked, a physical examination was done, and a standard 12-lead ECG was recorded at 2-6 month intervals. Calcium channel blockers were administered to 24 patients, but were not prescribed to the remaining 2 patients because of side effects. When angina attacks re-occurred, long-acting nitrates were added, the calcium channel blocker was changed and the dosages were increased to the maximal amount. All patients with cardiac events had been on medication when the event occurred. Clinical information was obtained from outpatient department records and from the primary physicians and the remaining information from telephone interviews. The actual follow-up period ranged Kaplan-Meier event-free survival curves for serious cardiac events in the 3 groups. The survival free of serious events was significantly lower for patients with sequential and/or simultaneous multivessel spasm (group 3) than for those with single vessel spasm (group 1) (p<0.001) or with migratory multivessel spasm (group 2) (p<0.05), whereas no significant difference was found between groups 1 and 2 (p=ns). Kaplan-Meier event-free survival curves for all cardiac events for the 3 groups. The survival free of cardiac events was significantly lower for patients with sequential and/or simultaneous multivessel spasm (group 3) than for those with single vessel spasm (group 1) (p<0.001) or with migratory multivessel spasm (group 2) (p<0.05), whereas no significant difference was found between groups 1 and 2 (p=ns). Japanese Circulation Journal Vol.63, July 1999 from 4 to 66 months. To define the relationship between prognosis and the pattern of coronary spasm, we divided the patients into 3 subgroups according to the patterns of ST segment elevation documented with the EAGLE system: single-vessel spasm (group 1), migratory spasm (group 2), and sequential and/or simultaneous spasm (group 3).
Statistical Analysis
Results are expressed as the mean ± SD. Continuous variables were analyzed by using analysis of variance. The chi-square test and Fisher's exact test were used to assess differences in categoric variables. The survival and eventfree survival curves were plotted by the Kaplan-Meier method and compared with the log-rank test. For all purposes, a 2-tailed p value less than 0.05 was considered significant.
Results

Clinical Characteristics
Clinical data are summarized in Table 1 . Of the 26 patients, single-vessel spasm was documented in 13 (50%) (patients 1-13). Of the remaining 13 patients, 6 had migratory spasm alone (patients 14-19), 1 had migratory as well as sequential spasm (patient 20), 1 had migratory as well as simultaneous spasm (patient 22), 4 had simultaneous spasm alone (patients 23-26), and the remaining 1 had all 3 types of multivessel spasm (patient 21). Spontaneous left main trunk spasm was observed at the beginning of coronary cineangiography in 2 of the 4 patients with the simultaneous type alone (patients 25 and 26).
Prognosis
All patients were followed up for at least 36 months or until death. During the follow-up period of 4-66 months (mean, 57.1±7.6 months), there were 10 cardiac events. Two patients died suddenly and 1 died of acute myocardial infarction. One patient suffered cardiopulmonary arrest, but was resuscitated successfully without serious sequelae. Another patient developed nonfatal acute myocardial infarction in hospital, in spite of continuous intake of intravenous isosorbide dinitrate and heparin, and a permanent pacemaker was implanted into a patient who had repeated episodes of cardiogenic shock with complete atrioventricular block during ischemic attacks. Four other patients were re-admitted with unstable angina. The remaining 16 patients were free from cardiac events. Table 2 shows the mean follow-up period, clinical background and treatment for the 3 groups of patients. The overall survival rate for patients in group 3 was significantly lower (p<0.05) than that for group 1, whereas for patients in group 2, the difference did not attain statistical significance in comparison with group 1 (p=ns) (Fig 1) . As shown in Fig 2, the survival rate free of fatal or nonfatal severe cardiac events, such as nonfatal myocardial infarction, cardiac arrest or permanent pacemaker implantation, for group 3 was significantly lower than for groups 1 (p<0.001) and 2 (p<0.05), whereas no significant difference was found between groups 1 and 2 (p=ns). Fig 3 shows the survival curves without any cardiac events, including re-admission with unstable angina. The survival rate for patients in group 3 was significantly lower than that for groups 1 (p<0.001) and 2 (p<0.05) whereas no significant difference was found between groups 1 and 2 (p=ns).
Discussion
Although it is generally believed that the prognosis of variant angina without significant organic stenosis is good, 9-12 sudden cardiac death has been reported in these patients. 2, 13 Previous studies have indicated that multivessel coronary spasm is an important predictor of survival in patients with variant angina 1-4 and the incidence of multivessel spasm has been reported to range from 25 to 76%. [5] [6] [7] If all patients with multivessel spasm were at high risk of sudden death, however, the prognosis should be worse, so there seems to be a low-risk subgroup among multivessel spasm patients.
We defined 3 different patterns of multivessel spasm (migratory, sequential, and simultaneous) and found that lethal arrhythmias occur more frequently during sequential and simultaneous spasm, 5 so these 2 types of spasm appear to be more dangerous than migratory spasm. 14 To determine whether the pattern of spasm influenced the prognosis of variant angina, we followed a group of patients prospectively. Although there were no significant differences in the clinical background and treatment of these 3 subgroups, the prognosis for the patients with simultaneous and/or sequential spasm was worse. In contrast, patients with migratory coronary spasm, a different pattern of multivessel spasm, seemed to have a better prognosis than for those with simultaneous and/or sequential spasm.
In the present study, we observed a discrepancy between the results of the EAGLE system monitoring and the ergonovine test with regard to the site of coronary spasm. The reason was considered to be that when, during ergonovine provocation, spasm was documented in one coronary artery, the study was terminated and the next higher dose of ergonovine was not given. Thus, the dosedependent effect of ergonovine on the other coronary arteries was not examined under this protocol. Intracoronary administration of acetylcholine is a useful method for the diagnosis of multivessel spasm in patients with variant angina, but this method cannot clarify whether the prognosis for this type of multivessel spasm is better (migratory type) or worse (sequential and/or simultaneous type). 6 The standard Holter monitor is used widely for the diagnosis of unstable angina, but recently it has been reported that the 12-lead continuous ECG monitoring system is superior in diagnostic sensitivity. 8, 15 Moreover, the 2 or 3-lead Holter monitor system cannot clearly distinguish the 3 type of multivessel spasm. Thus, our study suggested that it is necessary to document the angina attacks with 12-lead ECG recordings in patients with multivessel spasm in order to predict outcome.
Left Main Coronary Artery Spasm
Spasm of the left main coronary artery is rarely reported [16] [17] [18] [19] and very little is known about the long-term outcome of this condition. Ng et al demonstrated good prognosis for left main coronary spasm with pharmacological therapy, in the short-term. 19 In our study population, 2 patients had pharmacological therapy for left main coronary artery spasm and both of them died following cardiac events. Coronary artery bypass grafting and percutaneous transluminal coronary angioplasty (PTCA) can be effective in some cases of variant angina with significant organic stenosis. However, the overall results of these treatments are not as good in variant angina without fixed coronary stenosis. There is a higher incidence of occlusion of the grafts or restenosis in the case of PTCA. Sen et al described surgical angioplasty with good early symptomatic relief, 20 but there has been controversy regarding the effects of treatment for left main coronary spasm.
Study Limitations
There were several limitations to the present study. First, the population was too small for statistical assessment of overall survival and survival without cardiac events. However, it is clear that the patients with simultaneous and/or sequential spasm had a worse outcome than those with other types of coronary spasm. Second, the prevalence of spasm types was determined by the EAGLE system recording over a 24-h period. If the recording time had been extended, a higher prevalence of multivessel spasm might have been detected. There is also a possibility that the patient in the migratory spasm group who died suddenly might have developed sequential or simultaneous spasm during the fatal event.
According to previously reported clinical observations, we know that the simultaneous type of coronary spasm constitutes a high risk of sudden death. The patients in group 3 were therefore treated more carefully and appropriately than those with single-vessel spasm; if one kind of calcium channel blocker could not prevent spasm completely in such patients, other kinds were added. 21 In the outpatient department, the decision whether the patient was treated with a sufficient dose of medicine or not was reached mainly on the basis of patient interviews. Consequently, silent myocardial ischemia may have been neglected and the patient may not have taken an adequate dose of medication. 22 However, our study suggests that simultaneous and/or sequential spasm diagnosed by the EAGLE system may have an important influence on the prognosis of patients who have variant angina without fixed coronary stenosis.
